Diagnostic classification on HAM & Melanoma (joint)
77.47H-MeanDINOv2
Evaluation Results
| Method | Links | |
|---|---|---|
| DINOv2Superv. (%)=502026.05 | 77.47 | |
| DINOv2Superv. (%)=752026.05 | 77.08 | |
| DINOv2Superv. (%)=152026.05 | 76.32 | |
| SlotVAE (k=2)Superv. (%)=752026.05 | 76.19 | |
| DINOv2Superv. (%)=252026.05 | 75.96 | |
| DINOv2Superv. (%)=12026.05 | 75 | |
| SlotVAE (k=2)Superv. (%)=502026.05 | 73.94 | |
| SlotVAE (k=2)Superv. (%)=252026.05 | 72.01 | |
| GlobalVAESuperv. (%)=752026.05 | 71.65 | |
| SlotVAE (k=2)Superv. (%)=152026.05 | 71.12 | |
| RN+SA (k=2)Superv. (%)=502026.05 | 70.57 | |
| SlotVAE (k=2)Superv. (%)=12026.05 | 69.88 | |
| RN+SA (k=2)Superv. (%)=752026.05 | 69.41 | |
| GlobalVAESuperv. (%)=502026.05 | 67.88 | |
| GlobalVAESuperv. (%)=152026.05 | 67.84 | |
| RN+SA (k=2)Superv. (%)=252026.05 | 67.35 | |
| RN+SA (k=2)Superv. (%)=12026.05 | 65.25 | |
| RN+SA (k=2)Superv. (%)=152026.05 | 64.14 | |
| GlobalVAESuperv. (%)=252026.05 | 62.11 | |
| GlobalVAESuperv. (%)=12026.05 | 59.93 |